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Validity and Reproducibility of Self-Administered Joint 
Counts. A Prospective Longitudinal Followup Study in 
Patients with Rheumatoid Arthritis
MARLOU L.L. PREVOO, INA H. KUPER, MARTINA, vant  HOF, MIEK A. van LEEUWEN,
LEVINUS B A . van de PUTTE, and PIET L.C.M. van RIEL
ABSTRACT Objective. To investigate the reproducibility and validity of self-administered joint counts (JC), mea­
suring tenderness, swelling and the combination of both, in a longitudinal study.
Methods. At the outpatient department a form self-administered by patients (SAI-form), was used to 
measure joint involvement. Concurrent joint examinations were performed by an assessor. The JC 
and scores for groups of joints by assessors were correlated with those by patients. As a retest the 
form was completed again by the patients within 10 days. Correlations between the JC measured by 
the test and retest were computed to investigate reproducibility.
Results. Correlations between test and retest were high (> 0.7). Correlations between JC and groups 
of joints measured by the assessors and by the patients were moderate (0.6), Correlations with other 
disease activity variables did not differ between assessors' and patients’joint examination scores. 
Conclusion. The patient-administered joint examination was reproducible; however, correlation
with the assessors’joint examination was moderate. The value of the self-administered joint count
* i ,
needs further examination and cannot yet replace the assessor’s joint examination. (J Rheumatol
1996;23:841-5)
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Rheumatoid arthritis (RA) is a systemic illness with chron­
ic, symmetric polyarthritis as its most important clinical fea­
ture. Clinical evaluation of joints is considered important for 
the evaluation of an individual patient’s disease in daily 
clinical practice as well as in clinical trials1. However, since 
there is no consensus on how to best measure joint involve­
ment, many different types of joint counts (JC)2_5are in use. 
A recent study to evaluate several published JC for validity 
and reliability to measure disease activity6 concluded that 28 
JC that measure number of tender joints, swollen joints, or 
both tenderness and swelling were as valid and reliable as 
more comprehensive JC (i.e., JC with more joints and/or 
grading for tenderness, or weighting for surface area). 
Another study indicates that despite their simplified form, 
these JC were sensitive to changes in clinical trials in which
2 groups were compared7. Because of the validity, reliabili­
ty, sensitivity, and simplicity of these 28 JC (measuring ten-
derness and/or swelling), the 28 JC were chosen to be part 
of a validated standard set of criteria for the assessment of 
activity and outcome of RA (EULAR core set)8, and they 
were accepted as outcome measures in clinical trials by the 
American College of Rheumatology (ACR)9. Simpler and 
less time consuming would be a JC performed by the patient 
comparable to the self-administered visual analog scale 
(VAS) pain score, and functionality score by questionnaire. 
The self-assessment of joint involvement has been investi­
gated in 5 studies10”14, each evaluating a different question­
naire and a different JC. Our goal was to compare the valid- 
ity and reproducibility of self-administered JC to assess the 
disease activity in joints.
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MATERIALS AND METHODS
Patients already included in a followup study (begun in 1985) at the uni­
versities of Nijmegen and Groningen6*15 were asked to participate in this 
followup study. To be eligible patients with recent onset RA visiting the 
outpatient department o f the University o f Nijmegen (Clinic 1) or 
Groningen (Clinic 2) had to fulfil the following criteria: RA according to 
the 1987 ACR criteria, disease duration less than one year, and n o  previous 
disease modifying antirheumatic drugs (DMARD). The participants, 173 
patients from Clinic 1 and 101 patients from Clinic 2, were seen by 
research nurses and rheumatologists at least every 3 months.
In 1992, a self-administered joint evaluation form (SAJ) was devel­
oped. The SAJ form consisted of 2 mannequins to evaluate (1) swollen 
joints, and (2) tender joints (Figure 1). The following joints, indicated by a 
circle, were evaluated bilaterally for tenderness and swelling: the shoulder, 
elbow, wrist, each metacarpophalangeal (MCP), each proximal interpha- 
langeal (PIP) of the fingers, interphalangeal of the thumb, hip, knee, ankle, 
and each metatarsophalangeal (MTP). On all SAJ forms instructions were 
included: patients were asked to indicate which joints were tender (graded
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Figure 1. The self-administered form to indicate tender joints.
0 = no tenderness, 1 = slightly tender, 2 = moderately tender, 3 = very ten­
der) or swollen (not graded, 0  = not swollen, 1 = swollen). Help with 
instructions was provided the first time patients completed the SAJ form.
In Clinic 1, patients completed the first SAJ form (TEST) during a visit, 
under supervision of one observer (MP), who had no knowledge of disease 
activity or joint involvement. Patients were asked to complete the same 
SAJ form at home one day after their visit, and to return the form by pre­
paid mail (RETEST). Subsequent SAJ were mailed to patients about 1 
week before their 3 month visit. Forms were completed the morning of the 
visit, and collected by research nurses. In Clinic 2 patients completed the
Table 1. Definitions for assessor and patient JC.
first SAJ form under supervision of research nurses or rheumatologists 
prior to joint examination. Patients completed subsequent SAJ during visits.
In both clinics, 3 month joint examination was given by research nurs­
es or by rheumatologists (assessors). Joint scores were as follows: tender­
ness: (graded) 0 = not tender, 1 = tender, 2 = tender with wince response, 3 
= tender with wince and withdraw response; swollen joints: (binary) 0 = not 
swollen, 1 = swollen. Other assessments include pain on a 10 cm VAS: 0 = 
no pain, 10 = worst pain possible; general health on a VAS: 0 = best pos­
sible, 10 = worst possible; grip strength by vigorimeter (mm Hg), erythro­
cyte sedimentation rate (ESR) according to Westergren. Every 6 months the 
patients completed a Health Assessment Questionnaire (HAQ)16.
JC were calculated from assessor scores (assessors’ JC) and from 
patient SAJ forms (SAJ-JC). Joints excluded because patients found them 
difficult to identify include temporomandibular, sternoclavicular, acromio­
clavicular, subtalar, midtarsal, and the cervical spine. The following JC 
were calculated: modified Ritchie Articular Index f42 joints examined for 
tenderness (graded) 1, the total number of swollen joints (40 joints), total 
number of tender joints (42 joints), total number of joints that are tender as 
well as swollen (40 joints), as well as the Thompson count (THOM, 38 
joints examined for the combination of tenderness and swelling, in which 
the joints were weighted for surface area), 28 joint count measuring tender 
joints, 28 swollen joint count, and the combination of tenderness and 
swelling (28 T&S). Definitions of the JC are shown in Table 1.
Statistics. The reproducibility of the SAJ forms was determined by com­
paring results of TEST versus RETEST. After square root transformation of 
JC to obtain “normality,” Pearson correlation coefficients between TEST 
and RETEST JC were computed.
To investigate the validity of the SAJ-JC to measure joint involvement, 
assessor JC were considered the gold standard. Systematic differences 
between JC measured by patients (SAJ) and those measured by assessors 
were tested by Wilcoxon paired signed rank tests. Regression analyses were 
performed to control for systematic differences. Pearson correlation coeffi­
cients between JC of patients and assessors were computed.
RESULTS
Of 144 patients in Clinic 1 asked to participate 3 patients 
were unable to complete the SAJ form. A total of 141 
patients (98%) completed the first SAJ form. After complet­
ing the first SAJ form, these 141 patients were sent a total of 
327 SAJ forms of which 284 (87%) were returned. Some 
SAJ forms were not filled in correctly (for instance, grading 
for tenderness was missing) or the concurrent scores of the 
assessors were not available. A total of 386 SAJ forms
Joints No. of Joints RAI THOM 
(weigh Is)
28 T 28 T&S 28 S TOTT TOTT&S TOTS
Shoulder 2 + ---- + + + 4- + +
Elbow 2 + + (48) + + + + +
Wrist 2 + + (32) + + + + + +
MCP (1-5) 10 4* + (5) + + + + + +
PIP (1 -5 ) 10 + + (3) + + + + +
Flip 2 + ---- — — — + —
Knee 2 + + (95) + + + Hr + +
Ankle 2 + + (32) — — — + + +
MTP (1-5 ) 10 + + (8) — — — + +
RAI: Ritchie Articular Index; THOM: Thompson articular score; 28 T: 28 JC measuring tender joints; 28 T&S: 
28 JC measuring tenderness and swelling; 28 S: 28 JC measuring swollen joints; TOTT: total number of tender 
joints; TOTT&S: total number of joints measuring tenderness and swelling; TOTS: total number of swollen 
joints.
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(91%) of all SAJ forms (n = 425) could be used for further 
analyses. Patients who completed the first SAJ form (n = 
141), 111 (83%) completed retests within 10 days of the first 
test. At study start (at first SAJ) the median disease duration 
of these 141 patients was 3.8 years (25-75% interval: 
2.8-5.3 years), their median age was 59 years (25-75% 
interval: 51-67 years), 59% were women, and 81% were 
IgM rheumatoid factor positive (IgM RF > 10 IU). In Clinic
2, 95 patients participated and the total number of SAJ 
forms was 231 (no retest). Their median disease duration 
was 5.6 years (25-75% interval: 4.4-6.3 years); median age 
was 56 years (25-75% interval: 41-63 years); 69% were 
women, and 83% IgM RF positive.
Correlations between TEST and RETEST JC ranged 
from 0.77 to 0.87. Correlations measuring a combination of 
tenderness and swelling [THOM (0.77), 28 T&S.-(0.78)}.
were lowest.
Median values of assessor and JC patient for both clinics 
are shown in Table 2. All JC except 28 measuring swollen 
joints are significantly different (systematic difference) 
between the assessors and the patients (p value Wilcoxon’s 
signed rank tests < 0.05). In both clinics an overestimation 
of patient versus assessor JC was observed. Pearson correla­
tion coefficients between assessor JC (gold standard) and 
patient JC are presented in Table 3. The range of correlations 
of all JC was 0.48-0.65 for Clinic 1 and 0.47-0.65 for Clinic
2. Also, correlations between assessor JC and SAJ-JC were 
computed separately for 3 observers (data not shown). 
These did not differ from the overall correlations.
To identify whether the low correlations between asses­
sors and patients could be explained by specific joints, we 
determined assessor-patient agreement for groups of joints. 
To group the large number of joints, principal component 
analyses were performed separately for scores measuring 
swelling and tenderness (nongraded, binary). For both char­
acteristics, similar groups for the patients and assessors 
(eigenvalue > 1 )  were found. The following 7 groups could 
be formed: MCP, PIP, MTP, and all large joints (wrists, 
ankles, knees, shoulders). In further analyses these large 
joints are grouped together. The reliability of the 4 groups
Table 3. Pearson correlations between the assessor and patient JC.
Nijmegen Groningen
Clinic 1 Clinic 2
(n = 386) (n = 229)
RAI 0.62 0.65
THOM 0.48 0.47
28 T 0.62 0.60
28 T&S 0.56 0.61
28 S 0.61 0.65
TOTT 0.65 0.60
TOTT&S 0.53 0.61
TOTS 0.51 0.64
RAI: Ritchie Articular Index; THOM: Thompson articular score; 28 T: 28 
JC measuring tender joints; 28 T&S: 28 JC measuring tenderness and 
swelling; 28 S: 28 JC measuring swollen joints; TOTT: total number of ten­
der joints; TOTT&S: total number of joints measuring tenderness and 
swelling; TOT: total number o f  swollen joints.
measured by the assessors or patients both for tender and 
swollen joints was determined by Cronbach’s alphas rang­
ing as follows: MCP 0.84-0.92, PIP 0.87-0.93, MTP 
0.91-0.94, and large joints 0.58-0.86. The correlations 
(nonparametric, Spearman rank correlations) between the 
mean scores of the groups of joints scored by the assessor 
and by the patients are presented in Table 4. The correlation 
for swelling of the MTP is low, and differs significantly (p < 
0.05) from the correlations of all other groups of joints.
As low correlations were found between assessor and 
patient JC and groups of joints, we computed correlations of 
patient and assessor scores with other disease activity vari-
Table 4. Spearman correlations between assessor and patient (n = 615) 
scores for groups of joints.
Spearman Correlations between Assessors and Patients
Tenderness Swelling
MTP 0.48 0.25*
PIP 0.5 Í 0.56
MCP 0.50 0.57
LJ 0.52 0.54
* Significantly (p < 0.05) different from the other correlations.
LJ: group o f joints including wrists, ankles, knees, shoulders, elbows.
Table 2. Median values, differences and their (plO, p90) of assessor and patient JC.
JC Assessor JC
Nijmegen 
Clinic 1 (n = 386)
Patient JC Median Difference
Assessor-Patient
P* Assessor JC
Groningen
Clinic 2 (n = 229)
Patient JC Median Difference
Assessor-Patient
p*
RAI 3 (0, 10) 10 (0, 26) -5  (-1 8 ,0 ) <0.01 5 (0, 18) 5 (0 ,2 1 ) 0 (-9 , 5) 0.02
THOM 17 (0, 193) 57 (0, 288) -16  (-212, 38) <0.01 5 (0, 98) 1 2 (0 , 175) 0 (—136, 32) < 0.01
28 T 2 (0, 10) 7 (0, 24) -4  (-16, 0) <0.01 2 (0, 13) 3 (0, 18) 0 (-7 , 4) <0.01
28 T&S 1 (0, 7) 3 (0, 14) -1 (-8, 2) <0.01 1 (0, 6) 1 (0, 10) 0 ( - 5 ,  1) < 0.01
28 S 5 (1, 14) 4  (0, 16) 0 (-7, 7) 0.22 2 (0 , 11) 2 (0, 13) 0 (-6 , 4) 0.07
* Wilcoxon signed rank test; Due to ranking of values (patients have more extreme values) the signed rank test leads to significant results despite zero medi­
an values, RAI: Ritchie Articular Index; THOM: Thompson articular score; 28 T: 28 JC measuring tender joints; 28 T&S: 28 JC measuring the combination
of tenderness and swelling; 28 S: 28 JC measuring swollen joints.
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ables. For this correlation between patient and assessor 
scores for groups of joints with ESR, Pain on a VAS pain 
score, General Health on a VAS general health, grip 
strength, and HAQ were computed (Table 5). All Spearman 
rank correlations of scores for groups of joints with these 
variables do not significantly differ between assessors and 
patients. Similar results were found if tenderness was grad­
ed (not binary). There were no differences in correlations 
between the 2 clinics.
DISCUSSION
In the assessment of disease activity in patients with RA, 
there is an increase in the use of self-administration forms,
r
such as questionnaires to assess function, VAS to measure 
pain, general health, and global disease activity. In recent 
years, self-administered forms to measure joint involvement 
including JC 10-14 have been evaluated. Although an attempt 
was made to test the validity of these different SAJ-JC, a 
comparison of SAJ-JC with assessor JC has never been 
made. We evaluated available SAJ-JC, including 28 JC 
recently shown to be reliable and valid measurements of dis­
ease activity6, in a large cohort of patients with RA.
In view of the level of difficulty of the SAJ forms the 
response rate to the SAJ form was high. Since most patients 
were capable of filling in the SAJ form correctly, the num­
ber of forms used in the analyses was high.
Reproducibility of the self-administered JC appeared sat­
isfactory, and comparable to test-retest correlations of other 
assessments16”18.
However, the validity of SAJ-JC with respect to the 
assessor JC is low. This low correlation could not be 
explained by differences in the number of joints, in weight­
ing of joints, and/or grading of tenderness (comprehensive 
JC showed as low a correlation as 28 JC). No difference 
resulted from the way the SAJ form was introduced and 
explained to patients in Clinic 1 versus 2. Finally, no group 
of joints could explain these low correlations. If  the purpose 
of the self-administered score is to replace the assessor
score, correlation between these scores should be higher 
than 0.9, and, after correction for systematic differences, 
scores should be almost identical. On the basis of our results 
we conclude therefore that joint involvement measured by 
assessors cannot be replaced by patient self-administered 
scores. In 4 of 5 studies evaluating self-administered JC it 
was concluded that validity of self-administered JC to mea­
sure assessor JC was good10"13; however, correlations in 
these studies range from 0.40 to 0.89. Only Hewlett, et al 
concluded correctly that the validity to assess assessor JC 
was low14, in agreement with our results.
We found the correlation between assessor and patient 
scores for swelling of the MTP was low, and differs signifi­
cantly (p < 0.05) from the correlations of all other groups of 
joints. Smolen, et al19 found a clear cut dissociation between 
the measurement of joint pain and swelling of the MTP 
joints by assessors, which could indicate that the assessment 
of swelling in MTP joints is more difficult than in other 
joints; or MTP joint tenderness may reflect processes differ­
ent from those of the underlying disease. The low correla­
tion between the assessor and patient joint scores for 
swelling of MTP confirms that the measurement of these 
scores differs from all other joints.
Due to the low validity versus assessor scores, the rela­
tion of the self-administered scores with some other disease 
variables was computed, The relation of the SAJ scores with 
these disease variables did not differ from the assessor 
scores.
In our study the assessor score was taken as the gold stan­
dard. Agreement between patient and assessor scores was 
low compared to correlation coefficients for the Ritchie 
score (range 0.91 to 98) between 3 assessors3. However, cor­
relation of patient scores with other disease activity vari­
ables was comparable with that of assessor scores with these 
variables. Thus, there should be further investigation to 
determine whether patient scores would be useful in clinical 
trials and in daily clinical practice.
We conclude that the reproducibility of the self-adminis-
Table 5, Spearman rank correlations between patient and assessor scores for groups of joints (patient-assessor) versus other disease activity variables.
ESR 
(n = ±  615)
Pain 
(n = ~ 615)
GH 
(n = ± 386)
Grip
Strength
(n = ± 615)
HAQ 
(n = ± 190)
Pain: VAS measuring pain; GH: VAS measuring general health; LJ: group of joints including wrists, ankles, knees, shoulders, elbows.
Assessor Patient Assessor Patient Assessor Patient Assessor Patient Assessor Patient
Tenderness
MTP 0.01 0.12 0.34 0.23 0.36 0.25 0.20 0.20 0.32 0.37
PIP 0.11 0.14 0.39 0.35 0.38 0.35 0.27 0.27 0.37 0.37
MCP 0.08 0.16 0.43 0.36 0.41 0.36 0.33 0,26 0,42 0.29
LJ 0.06 0.17 0.50 0.44 0.45 0.36 0.32 0,34 0.50 0.39
Swelling »
MTP 0.07 0.03 0.28 0.23 0.23 0.14 0.10 0.22 0.16 0.18
PIP 0.02 0.09 0.22 0.29 0.18 0.15 0.23 0.25 0.19 0.15
MCP 0-06 0.14 0.33 0.35 0.24 0.13 0.26 0.24 0.21 0.14
LJ 0.07 0.21 0.38 0.32 0.28 0.19 0.31 0.33 0.39 0.24
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tered forms to determine joint involvement was good in this 
population. Agreement between health professionals and 
patients was low for JC as well as for groups of joints. The 
relation of self-administered scores for groups of joints with 
other disease variables, however, did not differ from the 
assessor scores. Although self-administered joint involve­
ment scores cannot yet replace the joint examination by 
health professionals, further studies should investigate their 
place in the assessment of RA.
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